How Much NMN Per Day? Science-Based Dosing Guide (2026)
If you're starting NMN, the question that decides whether your protocol works is simple: how much should you take?
This guide answers that question from the published clinical trial evidence, not marketing intuition. Short answer first, then the science.
The short answer
250–500 mg of NMN per day is the standard research-supported dose. Start at 250 mg for the first two weeks to assess tolerance. If well-tolerated, move to 500 mg as your standard daily dose. Take it in the morning, with or without food, every day.
If you want more nuance: the 2023 Yi et al. dose-response trial identified 600 mg/day as the clinically optimal point for functional improvements like walking distance.[2] 500 mg sits at the practical sweet spot — comfortably within the published-effective range, well within published safety limits, and cost-effective for daily use.
Doses above 600 mg produce more NAD+ elevation but diminishing additional functional benefit. Doses above 900 mg push past the published trial maximum (other than personal protocols).
What the trials actually used
The published human clinical trial dose range:
| Trial | Dose | Duration | Population | Result |
|---|---|---|---|---|
| Yoshino 2021 (Science)[1] | 250 mg/day | 10 weeks | Prediabetic women | +25% muscle insulin sensitivity |
| Okabe 2022 (Frontiers Nutr)[3] | 250 mg/day | 12 weeks | Healthy adults | Significant NAD+ elevation, no safety issues |
| Morifuji 2024 (GeroScience)[4] | 250 mg/day | 12 weeks | Older adults (65–75) | Improved walking speed + sleep |
| Yi 2023 (GeroScience)[2] | 300, 600, 900 mg/day | 60 days | Healthy middle-aged | All raised NAD+; 600 mg optimal for function |
| Mills 2016 (Cell Metab, mouse)[5] | 100, 300 mg/kg/day | 12 months | C57BL/6N mice | Mitigated age-associated decline, no toxicity |
| Dr. David Sinclair (personal) | ~1,000 mg/day | Ongoing | Self-reported | (no published outcomes from personal use) |
The pattern: 250 mg has been enough in multiple trials to produce measurable metabolic and functional improvements. 600 mg is the published dose-response optimum. 1,000+ mg is the personal-protocol territory with strong safety data but diminishing returns.
How to dose NMN: practical protocol
Week 1–2: Start at 250 mg/day
Take one 250 mg dose in the morning. This is the dose used in the Yoshino 2021 Science trial that produced significant insulin-sensitivity gains in prediabetic women, and in the Okabe 2022 and Morifuji 2024 trials that established safety and NAD+ elevation in healthy adults and older adults respectively.
Assess tolerance. The first one to two weeks is when any mild side effects (nausea, flushing, fatigue) would appear if they're going to. Most users have none.
Week 3 onward: Move to 500 mg/day
If 250 mg/day was well-tolerated for two weeks, increase to 500 mg/day as your standard dose. This sits comfortably within the published-effective range, gets close to the 600 mg functional optimum identified in the Yi 2023 dose-response trial, and is cost-effective for continuous daily use.
Some users may prefer to split the dose (250 mg in the morning + 250 mg in early afternoon) for steadier NAD+ availability. There's no strong clinical evidence for divided dosing being superior — once-daily morning dosing is well-validated and simpler to maintain.
Optional: Push toward 600–900 mg/day
If you want to chase the maximum-effect dose from the trial literature, 600 mg/day is the Yi 2023 published optimum. 900 mg/day has confirmed safety from the same trial. Above 900 mg/day exits the published-trial range (other than personal protocols).
For most people, the 500–600 mg/day range captures the majority of the available benefit. Pushing higher is reasonable but not necessary.
When to take NMN
Morning is the standard recommendation. Two reasons:
- Circadian alignment. NAD+ levels naturally cycle with your circadian rhythm, peaking in the morning. Aligning NMN intake with the natural NAD+ rhythm makes physiological sense.
- Avoid late-day cellular energy signaling. Elevated NAD+ activates sirtuins and supports mitochondrial activity. For sleep quality, you want this cellular activity to ramp down by late evening. Morning dosing avoids any potential sleep disruption.
Published trials have generally administered NMN in the morning. There's no clinical evidence that other timings reduce efficacy, but morning is what the trial literature supports.
With or without food? Either works. Some users find taking NMN with a small amount of food reduces occasional GI discomfort. The published trials have used both protocols.
Consistency matters more than dose
Here's something the dose discussion often misses: your daily consistency has more impact than the exact milligram figure.
NAD+ levels respond to chronic dosing. Blood NAD+ rises within 2–4 weeks of daily NMN supplementation. Stop dosing, and NAD+ returns to baseline within about 4 weeks (per Okabe 2022).[3] Missing days mid-protocol resets the trajectory.
500 mg daily, taken consistently for 12 weeks, will produce a better NAD+ response than 1,000 mg taken 4 days a week. Pick a dose you can sustain. The functional benefits from the published trials all come from continuous daily protocols, not intermittent high doses.
Should you cycle NMN or take breaks?
No clinical evidence supports cycling. Published trials have used continuous daily dosing for 8–12 weeks. Dr. Sinclair has publicly reported taking NMN daily for years. The mouse foundational study used 12 months of continuous dosing without toxicity.[5]
The biological logic also doesn't support cycling: NAD+ levels respond to consistent supply. Cycling would simply mean lower average NAD+ levels. The supplement isn't pharmacologically similar to compounds where tolerance or receptor downregulation requires breaks (NMN is metabolic substrate, not a receptor agonist).
Take it every day.
Safety at different doses
NMN has shown an excellent safety profile across the published trial dose range. A 2024 systematic review of 10 RCTs covering 437 participants (doses 150–1,200 mg/day for 4–12 weeks) reported no serious adverse effects; only 8.2% of participants reported any mild side effects, all judged independent of NMN supplementation.
Dose-by-dose safety summary:
- 250 mg/day for 12 weeks — well-tolerated, no adverse events (Okabe 2022, Morifuji 2024).[3][4]
- 300–900 mg/day for 60 days — no safety issues at any dose (Yi 2023).[2]
- 1,000+ mg/day (personal protocol) — no published safety data; informally well-tolerated based on self-reported Sinclair-era protocols.
Regulatory note: NMN is a lawful dietary supplement ingredient in the US. On September 29, 2025, the FDA confirmed that NMN is not excluded from the definition of a dietary supplement, reversing its 2022 restriction. NMN supplements sold in the US in 2026 operate within FDA dietary supplement rules. See the complete NMN guide for the full regulatory history.
Reported side effects are uncommon and mild: occasional nausea or GI discomfort in the first one to two weeks, mild flushing, transient fatigue. These resolve as supplementation continues. If they don't, drop dose and ramp back up over 2–4 weeks.
Pregnant, nursing, or medicated individuals should consult a physician before starting NMN at any dose.
What goes with NMN at your daily dose
Your daily NMN dose is one piece of the puzzle. Pairing NMN with the supporting compounds longevity research recommends amplifies the effect:
- 500–1,000 mg TMG (trimethylglycine) at the same time as NMN — replenishes the methyl groups NMN turnover consumes. Full TMG-with-NMN explainer →
- Resveratrol — sirtuin activator. Sirtuins are NAD+-dependent enzymes; without sirtuin activation, restored NAD+ doesn't fully translate downstream.
- Quercetin — senolytic. Clears senescent cells that drain NAD+ via CD38.
- Green Tea Extract (EGCG) — antioxidant + AMPK activator. Supports the mitochondrial environment NAD+ operates within.
This is the multi-pathway approach current longevity research increasingly recommends. Nadosei combines all five compounds — NMN, TMG, Resveratrol, Quercetin, Green Tea Extract — in a single capsule. 500 mg NMN per serving, 250 mg TMG, plus the supporting compounds. The complete starter longevity stack rather than five separate bottles.
The bottom line
500 mg NMN per day, taken in the morning, every day. Start at 250 mg for two weeks, then move up. That's the dose backed by published human clinical trials and what most longevity physicians recommend.
Higher doses (600–900 mg) are supported by published safety data and may push toward maximum NAD+ elevation, but the dose-response curve plateaus and the practical benefit-to-cost equation favors the 500 mg range.
The most important variable isn't the exact milligram count — it's your daily consistency. NMN works through chronic NAD+ elevation. Pick a dose you'll take every day, and stick to it.
FREQUENTLY ASKED
How much NMN should I take per day?
What's the best time of day to take NMN?
Should I take NMN with food?
Can I take more than 500 mg of NMN per day?
Do I need to cycle NMN or take breaks?
Why do some protocols use 250 mg and others use 1,000 mg?
References
- Yoshino M, Yoshino J, Kayser BD, et al.(2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science.[PMC8550608]
- Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, Thasma S, Andhalkar N, Avhad G, Kumbhar V(2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45(1):29-43.[PMC9735188]
- Okabe, K. et al.(2022). Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in Nutrition.[PMC9036060]
- Morifuji M, Higashi S, Ebihara S, Nagata M(2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience.[PMC11336149]
- Mills KF, Yoshida S, Stein LR, et al.(2016). Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism.[PMC5318253]
Comments (0)